Sensory Saturator Minimize Needle Injection Pain
|
By HospiMedica International staff writers Posted on 20 Jan 2022 |

Image: The ShotBlocker eases injection pain (Photo courtesy of Bionix)
A simple, non-invasive, and drug free device instantly reduces needle injection pain and anxiety at a fraction of the cost of other methods.
The Bionix (Maumee, OH, USA) ShotBlocker is a washable plastic pad that uses an array of blunt contact points to saturate the sensory signals around an injection site, distracting patients from the pain signals of the needle by utilizing the Gate Theory of Pain. The single-patient pad upholds a sterile environment during injection procedures, and also eliminates costs associated with resterilization, and is available in either 50 or 100 units per box. ShotBlocker is also available in a reusable form.
ShotBlocker blocks the pain of minor injections without using chemical refrigerant sprays, anesthetic creams, or electrical stimulation devices, and can be used for both intramuscular and subcutaneous injections. The device is positioned over the injection site, and the blunt contact points are pressed firmly against the skin. The shot is immediately administered through the central opening. After the injection, ShotBlocker is lifted from the skin and discarded, or given to the patient to retain until the next injection.
“I'm always trying to find solutions for patients to have the best experience in a medical setting. Getting shots can be scary, and sometimes painful, and I wanted to find a way to use science to make that experience better,” said James Huttner, MD, PhD, medical director and vice president of product development for Bionix, who invented the ShotBlocker. “If anxiety or pain is an obstacle for children to receive the COVID-19 vaccine, I think the ShotBlocker can make a real difference.”
The Gate Control theory of pain contends that non-painful inputs can override and reduce painful sensations, “shutting down” the final common pathway for sharp pain to the brain by exciting nerves that transmit cold and vibration senses, just as running a burn under cold water stops the sharp pain. The theory, proposed in 1965 by Ronald Melzack and Patrick Wall, offers a physiological explanation for the previously observed effect of psychology on pain perception.
Related Links:
Bionix
The Bionix (Maumee, OH, USA) ShotBlocker is a washable plastic pad that uses an array of blunt contact points to saturate the sensory signals around an injection site, distracting patients from the pain signals of the needle by utilizing the Gate Theory of Pain. The single-patient pad upholds a sterile environment during injection procedures, and also eliminates costs associated with resterilization, and is available in either 50 or 100 units per box. ShotBlocker is also available in a reusable form.
ShotBlocker blocks the pain of minor injections without using chemical refrigerant sprays, anesthetic creams, or electrical stimulation devices, and can be used for both intramuscular and subcutaneous injections. The device is positioned over the injection site, and the blunt contact points are pressed firmly against the skin. The shot is immediately administered through the central opening. After the injection, ShotBlocker is lifted from the skin and discarded, or given to the patient to retain until the next injection.
“I'm always trying to find solutions for patients to have the best experience in a medical setting. Getting shots can be scary, and sometimes painful, and I wanted to find a way to use science to make that experience better,” said James Huttner, MD, PhD, medical director and vice president of product development for Bionix, who invented the ShotBlocker. “If anxiety or pain is an obstacle for children to receive the COVID-19 vaccine, I think the ShotBlocker can make a real difference.”
The Gate Control theory of pain contends that non-painful inputs can override and reduce painful sensations, “shutting down” the final common pathway for sharp pain to the brain by exciting nerves that transmit cold and vibration senses, just as running a burn under cold water stops the sharp pain. The theory, proposed in 1965 by Ronald Melzack and Patrick Wall, offers a physiological explanation for the previously observed effect of psychology on pain perception.
Related Links:
Bionix
Latest Patient Care News
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







